Browsing: guide

The artificial intelligence (AI) sector currently remains one of the most powerful growth engines in the global equity market. Following years of rapid development, 2026 has brought both eye-popping rallies and localized corrections to AI-focused stocks and thematic funds, mapping divergent performance paths. 

A histology-based artificial intelligence (AI) biomarker may help personalize adjuvant chemotherapy selection for patients with resected pancreatic ductal adenocarcinoma, according to the results of a study by Beaufils et al. The investigators developed and validated a deep learning model that analyzes routine histology slides to predict the relative benefit of adjuvant gemcitabine vs modified FOLFIRINOX…